News

Tuesday, 19 November 2013 - 17:04

- Janssen must run a Phase III trial of bedaquiline urgently
 
- More investment in TB drugs and diagnostics urgently needed
 
The current standard of care for multi-drug resistant tuberculosis (MDR-TB) consists of poorly tested drugs with horrible side-effects. We are desperately in need of new properly tested TB drugs.
 
Bedaquiline, made by the pharmaceutical company Janssen (a subsidiary of Johnson & Johnson), is a promising drug for treating drug-resistant TB.  Two phase II trials have shown compelling evidence that the drug is effective at...

Read more
Thursday, 17 October 2013 - 06:19

Health activists hand-over comments on Draft Policy to Dept. of Trade & Industry, supporting patent law reform
 
PRETORIA, 17 October - Marching in support of government-proposed patent law reforms, Doctors Without Borders (MSF), the Treatment Action Campaign (TAC), and SECTION27 today handed their submission commenting on the Draft National Policy on Intellectual Property, 2013 to the Department of Trade and Industry (DTI).
 
“This policy is not just about legal technicalities. It will directly affect the health and lives...

Read more
Thursday, 17 October 2013 - 06:09

Over 130 organisations and experts globally have called on the South African Department of Trade and Industry to Fix the Patent Law in an open letter delivered this morning. You can find a PDF of the open letter here. The Fix the Patent Law campaign thanks all signatories for their support for improving access to medicines in South Africa!
 
--
 
Civil society open letter to the Department of Trade and Industry (...

Read more
Thursday, 17 October 2013 - 05:53

 
Today the Treatment Action Campaign (TAC), Médecins Sans Frontières (MSF), and SECTION27 handed in a submission to the Department of Trade and Industry in Pretoria, in response to the draft National Policy on Intellectual Property, 2013. Having worked for many years to limit the negative impact of intellectual property (IP) on public health, most recently through the Fix the Patent Laws campaign we welcome this opportunity to participate in the policy making process.
 
Below are our list of recommendations for the DTI. ...

Read more
Thursday, 10 October 2013 - 19:41

As the Fix the Patent Laws campaign gains traction and South Africa moves closer towards the kind of intellectual property reform that will vastly improve access to affordable medicines, a number of claims are being publicised by the pharmaceutical industry and their allies seeking to protect their business interests. The purpose of this myth-buster is to clarify that adopting legal TRIPS safeguards will not only support public health efforts but also benefit local industry and economic development.
 
The evidence highlights how South Africa’s current intellectual property...

Read more

Pages